You are here

HIV Management: The New York Course (VIRTUAL)

This advanced CME activity will provide participants with state-of-the-art information and practical guidance from internationally recognized experts on progress in managing HIV and viral hepatitis, including drug development and treatment, management of important comorbidities, and drug-drug interactions. The discussions at this meeting will allow clinicians to provide the highest quality of care in a variety of practice settings.

The primary goals of this activity are to increase each attendee’s competence to:

  • Identify new antiretroviral drugs and drug combinations while exploring answers to uncertainties in treatment strategies

  • Determine optimal approaches to diagnosis and treatment of important co-morbidities in patients with HIV infection, such as tuberculosis, malignancies and sexually transmitted infections

  • Detail current and developing treatment options for managing patients with viral hepatitis and its complications, including in special populations

  • Examine advances as well as controversies related to the transplantation of infected organs

  • Evaluate approaches and expert strategies geared toward preventing care provider burnout

  • Detail the impact of COVID-19 on HIV treatment and efforts to end this pandemic as well as the global epidemic of HIV

  • Identify HIV medication-related adverse drug reactions and offer strategies on how to best manage the outcomes

  • Recognize the significant HIV medication-related drug interactions, and when necessary offer alternative strategies to treatment